Globus Medical (GMED) Long-Term Investments (2013 - 2026)

Globus Medical (GMED) has reported Long-Term Investments for 14 consecutive years, with $245.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Investments changed N/A year-over-year to $245.4 million; the trailing twelve-month figure through Jun 2026 stood at $245.4 million (changed N/A YoY), and the FY2025 full-year result was $71.8 million, up 8.6% from the prior year.
• Long-Term Investments rose to $245.4 million in Q2 2026 per GMED's latest filing, from $169.4 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $546.9 million in Q1 2022 and bottomed at $12.3 million in Q3 2024.
• Historically, Long-Term Investments has averaged $244.0 million across 5 years, with a median of $207.4 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments plunged 95.54% in 2024, then soared 35.68% in 2025.
• Over 5 years, Long-Term Investments stood at $495.9 million in 2022, then plunged by 84.79% to $75.4 million in 2023, then retreated by 12.32% to $66.1 million in 2024, then climbed by 8.6% to $71.8 million in 2025, then surged by 241.63% to $245.4 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $245.4 million, $169.4 million, and $71.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.